FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

RELCAPITAL Consensus Forecast

No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%

RELCAPITAL Price Target Potential

BrokerageTargetPotential

RELCAPITAL Targets in FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for RELCAPITAL
0% Bullish
0% Bearish
See buy or sell ideas on FrontPage Forums >>

RELCAPITAL Ratings

Long term RELCAPITAL rating by FrontPage users
0/5 (0 Ratings)0

0 RELCAPITAL share price target reports by brokerages below. See what is analyst's view on RELCAPITAL share price forecast, rating, estimates, valuation and prediction behind the target. You may use these research report forecasts for long-term to medium term for your investment or trades in 2020.
  1. Home
  2. RELCAPITAL Forum
  3. RELCAPITAL Price Target

RELCAPITAL Share Price Target

RELCAPITAL Share Price Target - Broker Reports - 2018

27-Apr-18
Price @ Call: 434.65
Target: 660
BUY

RELCAPITAL Share Price Target - Broker Reports - 2017

16-Nov-17
Price @ Call: 422.75
Target: 660
BUY
Enhanced “Management Focus”, surge in earnings growth expected. Post demerger of housing finance, Reliance Nippon Life AMC IPO saw huge demand and valued the company at 6.8x AUM. Factoring Reliance capital stake down to 42% from 46% in AMC and with the holding company discount rising to 20%, we get the SoTP valuation at |700 per share. We further reduce |40 per share of funded exposure to reliance communication Reliance Infratel. Accordingly, we value the stock at |660 per share. We maintain our BUY rating on the stock. Expected IPO of GI seen before March 2018. We expect PAT to grow at 19% CAGR in FY17-19E not factoring capital gains from IPO. We expect RoE to move to double digits by FY19E with improving RoE of individual businesses. Recent default by promoter group entity in one of its dollar bond payments have led to sharp correction in ADAG group stocks including Reliance capital. The stock is trading at 0.7x FY19E ABV.
... Read more
21-Aug-17
Price @ Call: 783.35
Target: 905
BUY
We expect consolidated PAT to grow at 15% CAGR to | 1426 crore over FY17-19E not factoring in capital gains from IPO and other asset sale. The same can add | 800-1000 crore to capital gains. Improving RoE of individual businesses will push up consolidated RoE. FY18E may see ~12% RoE due to capital gains. However, normalised RoE is seen at ~7- 9% in the next couple of years. Based on higher general insurance and AMC valuations, we revise our SoTP target price to | 905 vs. | 775 earlier, with 10% holding company discount. At 1.3x for FY19E ABV valuations are still reasonable. We reiterate our BUY recommendation on the stock.
... Read more
28-Jul-17
Price @ Call: 660
Target: 871
BUY
Reliance Capital’s (RCAP) Q1FY18 was characterised by steady performance across businesses. Key trends: a) Life insurance: Decline arrested, persistency improved, but sustenance key; b) General insurance: Growth sustained, combined ratio improved to 104% (115% in Q4FY17); c) Home finance: AUM up >50%, aims to sustain run rate; and d) Commercial finance: Business reorientation on track, AUM growth soft at 6% YoY; e) AMC: Robust growth. With operations spread across scalable businesses (benefitting from higher financial savings) and beefed up leadership team, focus is now on execution with an aim to build a profitable business and consequent improvement in RoE. RCAP’s focus on profitable growth with run down in non‐core assets is likely to not only enhance capital efficiency, but also improve core performance. Maintain ‘BUY’.
... Read more
28-Jul-17
Price @ Call: 700
Target: 775
BUY
16-Jun-17
Price @ Call: 605.1
Target: 767
BUY
29-May-17
Price @ Call: 549
Target: 718
BUY
28-Apr-17
Price @ Call: 665
Target: 767
BUY
28-Apr-17
Price @ Call: 665
Target: 774
BUY
20-Mar-17
Price @ Call: 603
Target: 754
BUY
14-Feb-17
Price @ Call: 484
Target: 540
BUY

RELCAPITAL Share Price Target - Broker Reports - 2016

24-Oct-16
Price @ Call: 549
Target: 645
BUY
22-Aug-16
Price @ Call: 464
Target: 498
HOLD
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • RELCAPITAL Share Price Target Today- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 39.5
    Upside Target 29.5
    Upside Target 19.5
    Pivot9.5
    Downside Target 19.5
    Downside Target 29.5
    Downside Target 39.5
  • RELCAPITAL Share Price Target weekly- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 39.65
    Upside Target 28.95
    Upside Target 18.6
    Pivot7.9
    Downside Target 17.55
    Downside Target 26.85
    Downside Target 36.5
  • RELCAPITAL Share Price Target monthly- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 313.58
    Upside Target 210.92
    Upside Target 19.58
    Pivot6.92
    Downside Target 15.58
    Downside Target 22.92
    Downside Target 31.58
  • RELCAPITAL Share Price Target today- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 39.5
    Upside Target 29.5
    Upside Target 19.5
    Pivot9.5
    Downside Target 19.5
    Downside Target 29.5
    Downside Target 39.5
  • RELCAPITAL Share Price Target weekly- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 38.95
    Upside Target 28.55
    Upside Target 18.3
    Pivot7.9
    Downside Target 17.5
    Downside Target 27.25
    Downside Target 36.85
  • RELCAPITAL Share Price Target monthly- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 310.92
    Upside Target 29.39
    Upside Target 18.44
    Pivot6.92
    Downside Target 15.39
    Downside Target 24.44
    Downside Target 32.92
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.
PrivacyTerms
FrontPage © 2020